These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 11207628)

  • 21. Decreased bone mass despite long-term estrogen replacement therapy in young women with Turner's syndrome and previously normal bone density.
    Lanes R; Gunczler P; Esaa S; Martinis R; Villaroel O; Weisinger JR
    Fertil Steril; 1999 Nov; 72(5):896-9. PubMed ID: 10560996
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Body composition and physical fitness are major determinants of the growth hormone-insulin-like growth factor axis aberrations in adult Turner's syndrome, with important modulations by treatment with 17 beta-estradiol.
    Gravholt CH; Naeraa RW; Fisker S; Christiansen JS
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2570-7. PubMed ID: 9253336
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect on growth of patients with Turner's syndrome treated with low estrogen doses.
    Ranke MB; Haug F; Blum WF; Rosendahl W; Attanasio A; Bierich JR
    Acta Endocrinol Suppl (Copenh); 1986; 279():153-6. PubMed ID: 3022520
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Specific, time-dependent actions of low-dose ethinyl estradiol administration on the episodic release of growth hormone, follicle-stimulating hormone, and luteinizing hormone in prepubertal girls with Turner's syndrome.
    Mauras N; Rogol AD; Veldhuis JD
    J Clin Endocrinol Metab; 1989 Nov; 69(5):1053-8. PubMed ID: 2507569
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Lindynette 20].
    Peichinova I
    Akush Ginekol (Sofiia); 2008; 47 Suppl 2():59-60. PubMed ID: 19496455
    [No Abstract]   [Full Text] [Related]  

  • 26. Growth hormone treatment in Turner's syndrome: short and long-term effects on metabolic parameters.
    Haeusler G; Frisch H
    Clin Endocrinol (Oxf); 1992 Mar; 36(3):247-53. PubMed ID: 1563078
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of estrogen on nonverbal processing speed and motor function in girls with Turner's syndrome.
    Ross JL; Roeltgen D; Feuillan P; Kushner H; Cutler GB
    J Clin Endocrinol Metab; 1998 Sep; 83(9):3198-204. PubMed ID: 9745426
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of luteinizing hormone-releasing hormone (LRH) upon bioactive and immunoreactive serum LH in patients with Turner's syndrome before and after oestrogen treatment.
    Celani MF; Montanini V; Marrama P
    Acta Endocrinol (Copenh); 1985 Jul; 109(3):304-8. PubMed ID: 3895799
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased hGH production rate after low-dose estrogen therapy in prepubertal girls with Turner's syndrome.
    Mauras N; Rogol AD; Veldhuis JD
    Pediatr Res; 1990 Dec; 28(6):626-30. PubMed ID: 2284161
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum thymidine activity and somatomedin-C levels in children and adolescents with Turner's syndrome: effect of chronic estrogen and progestogen replacement therapy.
    Guidoux S; Bozzola M; Larizza D; Schimpff RM
    Horm Res; 1986; 24(4):256-62. PubMed ID: 3781484
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Modern extremely low dose oral contraception with lindynette 20].
    Radinski G
    Akush Ginekol (Sofiia); 2008; 47 Suppl 2():40-2. PubMed ID: 19504706
    [No Abstract]   [Full Text] [Related]  

  • 32. Final height of patients with Turner's syndrome treated with growth hormone (GH): indications for GH therapy alone at high doses and late estrogen therapy. Italian Study Group for Turner Syndrome.
    Cacciari E; Mazzanti L
    J Clin Endocrinol Metab; 1999 Dec; 84(12):4510-5. PubMed ID: 10599710
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The effect of primary lack of estrogens and the influence of the age at the beginning of estrogen therapy on bone mineral density in patients with Turner's syndrome].
    Sowińska-Przepiera E; Andrysiak-Mamos E; Friebe Z; Kapczuk K; Pilarska K
    Endokrynol Pol; 2005; 56(2):145-53. PubMed ID: 16335682
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Final height in girls with Turner's syndrome treated with once or twice daily growth hormone injections. Dutch Advisory Group on Growth Hormone.
    Sas TC; de Muinck Keizer-Schrama SM; Stijnen T; van Teunenbroek A; Hokken-Koelega AC; Waelkens JJ; Massa GG; Vulsma T; Gerver WJ; Reeser HM; Delemarre-van de Waal HE; Jansen M; Drop SL
    Arch Dis Child; 1999 Jan; 80(1):36-41. PubMed ID: 10325756
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Volumetric bone mineral density in young women with Turner's syndrome treated with estrogens or estrogens plus growth hormone.
    Bertelloni S; Cinquanta L; Baroncelli GI; Simi P; Rossi S; Saggese G
    Horm Res; 2000; 53(2):72-6. PubMed ID: 10971092
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The place of miligest in the clinical practice ].
    Jakov B
    Akush Ginekol (Sofiia); 2008; 47 Suppl 2():10-2. PubMed ID: 19504702
    [No Abstract]   [Full Text] [Related]  

  • 37. Exaggerated effects of progestogen on uterine artery pulsatility index in Turner's syndrome patients receiving hormone replacement therapy.
    Biljan MM; Taylor CT; Matijevic R; Jones SV; Garden AS; Fraser WD; Diver MJ; Kingsland CR
    Fertil Steril; 1995 Dec; 64(6):1104-8. PubMed ID: 7589660
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolic and cardiovascular outcomes in a group of adult patients with Turner's syndrome under hormonal replacement therapy.
    Giordano R; Forno D; Lanfranco F; Manieri C; Ghizzoni L; Ghigo E
    Eur J Endocrinol; 2011 May; 164(5):819-26. PubMed ID: 21378088
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adrenocorticotrophin stimulation and HLA polymorphisms suggest a high frequency of heterozygosity for steroid 21-hydroxylase deficiency in patients with Turner's syndrome and their families.
    Larizza D; Cuccia M; Martinetti M; Maghnie M; Dondi E; Salvaneschi L; Severi F
    Clin Endocrinol (Oxf); 1994 Jan; 40(1):39-45. PubMed ID: 8306479
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Observations with anteovin in family planning advisory unit.
    Domány Z
    Ther Hung; 1988; 36(1):29-33. PubMed ID: 3388289
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.